Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Total 13F shares
-
2,444,820
-
Share change
-
-302,922
-
Total reported value
-
$2,399,065
-
Price per share
-
$0.98
-
Number of holders
-
17
-
Value change
-
-$179,460
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q2 2025
As of 30 Jun 2025,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,444,820 shares.
The largest 10 holders included
BML Capital Management, LLC, CHOREO, LLC, RENAISSANCE TECHNOLOGIES LLC, AlphaCore Capital LLC, CITADEL ADVISORS LLC, Koa Wealth Management, LLC, Royal Bank of Canada, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.